Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,004 DKK | -2.77% | +1.73% | -7.01% |
05-03 | GENMAB : A good start to 2024; guidance unchanged | |
05-03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.01% | 19.25B | |
+8.94% | 105B | |
-0.65% | 104B | |
+5.79% | 22.94B | |
-12.59% | 22.34B | |
-37.08% | 17.08B | |
-9.41% | 16.96B | |
+7.91% | 14.16B | |
+38.41% | 12.63B | |
+309.91% | 8.49B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab A/S : , Seagen Get FDA Priority Review of Tisotumab Vedotin for Recurrent Cervical Cancer